ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,189Medicare Part D Prescriptions Filled, Including Refills

Rank: 429 out of 2170

$434K Total Retail Price of All Prescriptions

Rank: 592 out of 2170

373 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 373 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

9% of this provider’s 373 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

3% of this provider’s 7,371 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
OMEPRAZOLE 338 216 1 2
SIMVASTATIN 331 243 2 1
HYDROCHLOROTHIAZIDE 299 227 3 9
ENALAPRIL MALEATE 289 234 4 64
LISINOPRIL 231 188 5 3
FUROSEMIDE 200 174 6 6
METFORMIN HCL 191 137 7 8
AMLODIPINE BESYLATE 189 171 8 4
HYDROCODONE-ACETAMINOPHEN 171 170 S3 9 7
ATENOLOL 169 134 10 23
CITALOPRAM HBR 166 108 11 19
LEVOTHYROXINE SODIUM 157 143 12 5
WARFARIN SODIUM 137 132 13 15
GABAPENTIN 134 122 14 14
GLIPIZIDE 133 122 15 62
METOPROLOL TARTRATE 132 132 16 10
ATORVASTATIN CALCIUM 130 128 17 12
SYNTHROID 119 81 18 27
ALENDRONATE SODIUM 119 106 18 36
PRAVASTATIN SODIUM 118 110 20 11
METOPROLOL SUCCINATE 110 79 21 13
LOVASTATIN 104 94 22 34
PAROXETINE HCL 100 96 23 65
NEXIUM 98 67 24 22
LOSARTAN POTASSIUM 96 84 25 21
DOXYCYCLINE HYCLATE 94 76 26 100
FLUTICASONE PROPIONATE 93 67 27 30
POTASSIUM CHLORIDE 89 55 28 16
SERTRALINE HCL 84 79 29 25
RANITIDINE HCL 79 54 30 40
PANTOPRAZOLE SODIUM 73 58 31 39
OXYCODONE HCL 70 48 S2 32 56
NADOLOL 69 62 33 335
SPIRONOLACTONE 66 55 34 71
TRAMADOL HCL 65 58 35 18
TAMSULOSIN HCL 62 62 36 33
DIOVAN 60 60 37 53
ESTRADIOL 58 32 R 38 151
JANUVIA 56 56 39 80
OXYBUTYNIN CHLORIDE ER 55 23 40 148
NAMENDA 54 54 41 48
ISOSORBIDE MONONITRATE ER 54 39 41 50
PRIMIDONE 53 53 43 319
ACTOS 53 37 43 108
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 35 43 20
CLOPIDOGREL 52 45 46 37
TRIAMCINOLONE ACETONIDE 51 47 47 128
MELOXICAM 50 44 48 28
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 4, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.